IP Library Granted Patent US 10,040,871
Granted Patent B2
US 10,040,871 · App. 13/927,311 · Granted Aug 7, 2018

Medical devices based on oxidized cellulose

Inventors: Valentino Tramontano (Brockton, MA); Phillip Blaskovich (Salem, MA); Rachit Ohri (Framingham, MA); Joshua Kennedy (Somerville, MA); Sajida Farooqi (Hamden, CT)
Assignee: Covidien LP
C08B15/02A61L27/20A61L27/34A61L27/58
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,040,871
App. No.
13/927,311
Granted
Aug 7, 2018
Kind
B2
Abstract

A process for dissolving modified cellulose includes contacting modified cellulose with a solvent in a mixture to form swelled modified cellulose and then contacting the mixture with a salt to dissolve the swelled modified cellulose. The dissolved modified cellulose is used to form at least one of a predictably degrading coating, film, or a fiber.

Claims (24)

1. A process comprising:

contacting an oxidized cellulose with a solvent under an inert atmosphere to form a swelled oxidized cellulose;

adjusting the swelled oxidized cellulose to a first temperature in a vessel which is initially heated to the first temperature from about 115° C. to about 145° C.;

contacting the swelled oxidized cellulose with a salt under the inert atmosphere to form an oxidized cellulose solution;

adjusting the oxidized cellulose solution to a second temperature from about 90° C. to about 120° C.; and

forming at least one of a coating or a film from the oxidized cellulose solution.

2. The process according to claim 1 , wherein the at least one of the coating or the film is formed by evaporating the solvent from the solution.

3. The process according to claim 1 , wherein the solvent is selected from the group consisting of N,N-Dimethylacetamide, N-methyl-2-pyrrolidinone, and combinations thereof.

4. The process according to claim 1 , wherein the salt is selected from the group consisting of lithium halides, sodium halides, potassium halides, and combinations thereof.

5. The process according to claim 1 , wherein the at least one of the coating or the film includes a final oxidized cellulose having a degree of oxidation from about 80% to about 120% of a degree of oxidation of the oxidized cellulose before contacting with the solvent.

6. The process according to claim 5 , wherein the at least one of the coating or the film includes a final oxidized cellulose having a molecular weight from about 80% to about 120% of the molecular weight of the oxidized cellulose before contacting with the solvent.

7. The process according to claim 1 , further comprising:

contacting the oxidized cellulose solution with at least one biocompatible plasticizer.

8. The process according to claim 7 , wherein the at least one biocompatible plasticizer is selected from lecithin, dibutyl sebacate, citric acid, polyethylene glycol, polypropylene glycol, or combinations thereof.

9. A process comprising:

contacting an oxidized cellulose with a solvent under an inert atmosphere to form a swelled oxidized cellulose;

adjusting the swelled oxidized cellulose to a first temperature in a vessel which is initially heated to the first temperature from about 115° C. to about 145° C.;

contacting the swelled oxidized cellulose with a salt under the inert atmosphere to form an oxidized cellulose solution;

adjusting the oxidized cellulose solution to a second temperature from about 90° C. to about 120° C.; and

forming at least one of a coating or a film from the oxidized cellulose solution,

wherein the at least one of the coating or the film includes a final oxidized cellulose having a degree of oxidation from about 80% to about 120% of a degree of oxidation of the oxidized cellulose before contacting with the solvent.

10. The process according to claim 9 , wherein the at least one of the coating or the film includes a final oxidized cellulose having a molecular weight from about 80% to about 120% of the molecular weight of the oxidized cellulose before contacting with the solvent.

11. The process according to claim 1 , wherein the salt is present in amounts from about 0.25% by weight to about 2% by weight of the oxidized cellulose.

12. The process according to claim 9 , wherein the salt is present in amounts from about 0.25% by weight to about 2% by weight of the oxidized cellulose.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2014
From: CONFLUENT SURGICAL, INC.
To: COVIDIEN LP
Reel/Frame 031957/0415 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: TRAMONTANO, VALENTINO; BLASKOVICH, PHILLIP; OHRI, RACHIT; KENNEDY, JOSHUA
To: CONFLUENT SURGICAL, INC.
Reel/Frame 031123/0478 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 3, 2013
From: FAROOQI, SAJIDA
To: COVIDIEN LP
Reel/Frame 031123/0837 →
Continuity (2)
Provisional Application 61665518 · Jun 28, 2012
Related Publication 20140005375A1 · Jan 2, 2014